|
|
|
|
lung cancer |
|
|
|
colorectal cancer |
|
|
|
breast cancer |
|
||
prostate cancer |
|
|
|
|
|||||
|
|
|
|
|
|
|
digestive system
colon |
252,400
105,500 |
132,300
49,000 |
120,100
56,500 |
133,600
|
71,900
|
61,700
|
respiratory system
lung and bronchus |
185,800
171,900 |
102,200
91,800 |
83,600
80,100 |
163,700
157,200 |
93,400
88,400 |
70,300
68,800 |
breast |
212,600
|
1300
|
211,300
|
40,200
|
400
|
39,800
|
prostate |
220,900
|
220,900
|
0
|
28,900
|
28,900
|
0
|
all causes |
2,417,798
|
cardiovascular diseases |
699,697
|
all cancers |
553,251
|
cerebrovascular diseases |
163,601
|
chronic lower respiratory diseases |
123,974
|
accidents |
97,707
|
diabetes mellitus |
71,252
|
influenza and pneumonia |
62,123
|
Alzheimer's |
53,679
|
nephritis, nephrotic syndrome, nephrosis |
39,661
|
septicemia |
32,275
|
suicide |
29,423
|
chronic liver disease, cirrhosis |
26,751
|
homicide |
19,727
|
primary hypertension, hypertensive renal disease |
19,054
|
pneumonitis due to solids and liquids |
17,392
|
all other causes |
408,231
|
|
presidential budget |
HIV/AIDS - (CDC-wide)
Research & Domestic (CDC-wide) Global (CDC-wide) |
$1,033,190,000
$789,427,000 $243,763,000 |
Emerging Infectious Disease |
$292,850,000
|
Breast/Cervical Cancer |
$201,065,000
|
National Occupational Research Agenda |
$67,897,000
|
Diabetes |
$61,480,000
|
Cancer Registries |
$39,500,000
|
Syphilis Elimination |
$37,413,000
|
Infertility |
$30,186,000
|
Hepatitis C |
$21,930,000
|
Vaccine Safety |
$14,367,000
|
Prostate Cancer |
$13,812,000
|
Arthritis |
$13,803,000
|
Global Malaria |
$13,000,000
|
Fetal Alcohol Syndrome |
$12,000,000
|
Colorectal Cancer |
$11,838,000
|
Pfiesteria |
$9,081,000
|
Autism |
$8,000,000
|
Hantavirus/Special Pathogens |
$7,022,000
|
Epilepsy |
$6,527,000
|
Comprehensive Cancer |
$4,691,000
|
Ovarian Cancer |
$4,596,000
|
Radiation |
$1,948,000
|
Skin Cancer |
$1,647,000
|
|
|
|
breast cancer |
$438,700,000
|
$19,436,000
|
AIDS |
$244,100,000
|
|
prostate cancer |
$203,200,000
|
$10,335,000
|
colorectal cancer |
$175,800,000
|
$4,245,000
(gastrointestinal) |
lung cancer |
$175,000,000
|
$6,400,000
|
leukemia |
$141,700,000
|
|
ovarian cancer |
$65,500,000
|
$7,790,000
|
|
|
HIV/AIDS, STD, TB prevention |
$1,044,070,000
|
chronic disease prevention and health promotion (see above) |
$749,708,000
|
immunization |
$552,572,000
|
infectious diseases control |
$317,582,000
|
injury prevention and control |
$142,832,000
|
|
(1997) |
(CDC, 2001) prevention |
(NCI, 2000) research |
cardiovascular disease |
|
|
|
all cancers
lung cancer colorectal cancer breast cancer prostate cancer |
- 2 - 4 |
2 (tobacco) 8 1 - |
- 4 - 3 |
diabetes |
|
|
|
HIV |
|
|
|